Place in Therapy Given the drugs novel mechanism of action, it should be used adjunctively in select patients who fail to respond optimally to other AEDs for treatment of partial seizures
[DOI] [PMC free article] [PubMed] [Google Scholar] 92.Rhrich M., Koelsche C., Schrimpf D., Capper D., Sahm F., Kratz A., Reuss J., Hovestadt V., Jones D.T., Bewerunge-Hudler M., et al
Similar Products Other products in Weight Loss & GLP-1 Tirzepatide 5mg*10vials Tirzepatide 10mg*10vials Tirzepatide 15mg*10vials Tirzepatide 20mg*10vials Tirzepatide 30mg*10vials Tirzepatide 40mg*10vials Why Customers Trust QSC 100% Delivery Guarantee If your package is seized or lost in transit, we reship at no extra cost no questions asked
Figure 7 Discussion In this meta-analysis, a significant weight reduction was found following GLP-1 agonist use, MD=-4.28, 95% CI , -5.06--3.49